Table 2. Cancer-specific characteristics of 227 704 cancer survivors living in Denmark on 1 January 2011.
Total, n=227 704, %a | Men, n=94 481, %a | Women n=133 223, %a | |
---|---|---|---|
Index cancer typeb | |||
Mouth, pharynx and larynx | 2 | 4 | 1 |
Esophagus, stomach and pancreas | 1 | 2 | 1 |
Colon and rectum | 11 | 13 | 10 |
Lung | 3 | 3 | 3 |
Breast | 23 | <1 | 39 |
Female genitalia | 10 | - | 17 |
Male genitalia | 13 | 32 | - |
Kidney and bladder | 8 | 14 | 4 |
Malignant melanoma | 8 | 8 | 9 |
Central nervous system | 6 | 6 | 6 |
Leukemias, NHL and HL | 7 | 9 | 5 |
Other cancers | 7 | 8 | 6 |
Age at diagnosis of index cancer (years) | |||
0–29 | 6 | 8 | 6 |
30–59 | 46 | 35 | 51 |
60–89 | 48 | 56 | 42 |
⩾90 | <1 | <1 | 1 |
Time since diagnosis of index cancer (years) | |||
<1 | 11 | 13 | 9 |
1–4 | 31 | 36 | 27 |
5–9 | 22 | 22 | 22 |
10–19 | 22 | 18 | 25 |
⩾20 | 15 | 11 | 18 |
No. of primary cancers after index cancerb | |||
0 | 93 | 93 | 93 |
1 | 7 | 7 | 7 |
⩾2 | 1 | 1 | 1 |
Abbreviations: HL=Hodgkin lymphoma; NHL=non-Hodgkin lymphoma.
The sum may exceed 100% due to rounding.
Excluding benign tumours, cancer in situ, and non-melanoma skin cancers.